Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.
Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...
Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback